Rx/Reimbursement Adult Incontinence in Germany

Value sales of rx/reimbursement adult incontinence in Germany continued to rise in 2024, mainly driven by ongoing high production costs and persistent inflation. On the other hand, retail volume sales continued to slowly decline. The demand for rx/reimbursement adult incontinence in Germany is primarily driven by the country's ageing population, as well as by persons experiencing post-surgical leakage issues, including post-partum.

Euromonitor International's Rx/Reimbursement adult incontinence in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2029 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Rx/Reimbursement Adult Incontinence in Germany
Euromonitor International
March 2025
List Of Contents And Tables
RX/REIMBURSEMENT ADULT INCONTINENCE IN GERMANY
KEY DATA FINDINGS
2024 DEVELOPMENTS
Germany’s ageing population is main consumer base for rx/reimbursement adult incontinence
Challenge of diagnosis and reimbursement process
Category experiences increasing competition from retail adult incontinence
PROSPECTS AND OPPORTUNITIES
Rising pressure on category from retail and away-from-home channels
Waning stigma surrounding incontinence to support consumers seeking help
Rise of digitalisation and government support for lower-income consumers
CATEGORY DATA
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2019-2024
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2019-2024
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2024-2029
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2024-2029
TISSUE AND HYGIENE IN GERMANY
EXECUTIVE SUMMARY
Tissue and hygiene in 2024: The big picture
2024 key trends
Competitive landscape
Retail developments
What next for tissue and hygiene?
MARKET INDICATORS
Table 5 Birth Rates 2019-2024
Table 6 Infant Population 2019-2024
Table 7 Female Population by Age 2019-2024
Table 8 Total Population by Age 2019-2024
Table 9 Households 2019-2024
Table 10 Forecast Infant Population 2024-2029
Table 11 Forecast Female Population by Age 2024-2029
Table 12 Forecast Total Population by Age 2024-2029
Table 13 Forecast Households 2024-2029
MARKET DATA
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2019-2024
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2019-2024
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2020-2024
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2021-2024
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2019-2024
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2019-2024
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2024
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2024-2029
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2024-2029
DISCLAIMER
SOURCES
Summary 1 Research Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings